
Discontinuation of insulin detemir - New measures for primary and secondary care
New OpenPrescribing and OpenPrescribing Hospitals measure to support work to manage the discontinuation of insulin detemir.
This is a beta version of OpenPrescribing Hospitals for testing and feedback purposes. Data and functionality may be incomplete. Please contact us if you find any issues or have feedback. Sign up for email alerts to stay updated.
Explore, analyse and compare hospital medicines data from NHS Trusts across England
View the data submission history for each NHS Trust in England over time and identify gaps in reporting.
View HistoryExplore a curated set of measures that highlight variation in medicines issued across NHS Trusts.
View MeasuresBuild your own analysis. Explore trends for individual products or groups of related products issued across NHS Trusts.
Start AnalysingOur latest blog posts and research papers
New OpenPrescribing and OpenPrescribing Hospitals measure to support work to manage the discontinuation of insulin detemir.
We have two new measures available now for SGLT-2 inhibitors.
Stay updated with notifications of new OpenPrescribing Hospitals features and data releases.
Under Development
OpenPrescribing Hospitals is currently under development and conducting user testing. If you are interested in accessing the platform, please contact us.
Follow our blog for updates on our progress or sign up for email alerts.